Formoterolum [Inn-Latin] en es it fr

Formoterolum [Inn-Latin] Brand names, Formoterolum [Inn-Latin] Analogs

Formoterolum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Formoterolum [Inn-Latin] Chemical_Formula


Formoterolum [Inn-Latin] RX_link

Formoterolum [Inn-Latin] fda sheet

Formoterolum_[Inn-Latin] FDA

Formoterolum [Inn-Latin] msds (material safety sheet)

Formoterolum_[Inn-Latin] MSDS

Formoterolum [Inn-Latin] Synthesis Reference

No information avaliable

Formoterolum [Inn-Latin] Molecular Weight

344.405 g/mol

Formoterolum [Inn-Latin] Melting Point

No information avaliable

Formoterolum [Inn-Latin] H2O Solubility

Slightly (as fumarate salt)

Formoterolum [Inn-Latin] State


Formoterolum [Inn-Latin] LogP


Formoterolum [Inn-Latin] Dosage Forms

Metered-dose (aerosol); Powder

Formoterolum [Inn-Latin] Indication

For use as long-term maintenance treatment of asthma in patients 6 years of age and older with reversible obstructive airways disease, including patients with symptoms of nocturnal asthma, who are using optimal corticosteroid treatment and experiencing regular or frequent breakthrough symptoms requiring use of a short-acting bronchodilator.

Formoterolum [Inn-Latin] Pharmacology

Formoterol is a long-acting selective beta2-adrenergic receptor agonist (beta2-agonist). Inhaled formoterol fumarate acts locally in the lung as a bronchodilator. In vitro studies have shown that formoterol has more than 200-fold greater agonist activity at beta2-receptors than at beta1- receptors. Although beta2-receptors are the predominant adrenergic receptors in bronchial smooth muscle and beta1-receptors are the predominant receptors in the heart, there are also beta2-receptors in the human heart comprising 10%-50% of the total beta-adrenergic receptors. The precise function of these receptors has not been established, but they raise the possibility that even highly selective beta2- agonists may have cardiac effects.

Formoterolum [Inn-Latin] Absorption

Rapidly absorbed into plasma following administration by oral inhalation. It is likely that the majority of the inhaled formoterol delivered is swallowed and then absorbed from the gastrointestinal tract.

Formoterolum [Inn-Latin] side effects and Toxicity

An overdosage is likely to lead to effects that are typical of ß2-adrenergic stimulants: nausea, vomiting, headache, tremor, somnolence, palpitations, tachycardia, ventricular arrhythmias, metabolic acidosis, hypokalemia, hyperglycemia.

Formoterolum [Inn-Latin] Patient Information

Formoterolum [Inn-Latin] Organisms Affected

Humans and other mammals